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Mounting evidence suggests that common infections transiently increase risk for childhood arterial ischemic 
stroke (AIS), perhaps by causing an inflammatory state that 
promotes coagulation or endothelial injury. The NIH-funded 
VIPS study (Vascular Effects of Infection in Pediatric Stroke) 
confirmed a robust association between infection in the prior 
week and childhood AIS; the most common prestroke infec-
tions were upper respiratory (present in 50%).1 Serological 
assays for herpesviruses demonstrated a high prevalence of 
acute, mostly subclinical herpes infections.2
These findings present a paradox: childhood infection is com-
mon, whereas childhood stroke is rare. Although one possible 
explanation is an idiosyncratic immune response to infection 
contributing to stroke pathogenesis, another possibility is that 
unusual infections or combination of infections increase stroke 
risk. Although VIPS focused on herpesviruses, other infections 
could conceivably play a role. New MassTag–polymerase chain 
reaction (PCR) techniques allow for efficient, simultaneous test-
ing for a large number of pathogens. We performed a pilot study 
using this unbiased pathogen discovery approach to generate 
new hypotheses about the role of infection in childhood AIS.
Methods
The VIPS network of 37 enrolling sites enrolled and centrally con-
firmed 355 AIS cases and 354 stroke-free controls (2009–2014).1–3 
Trauma controls, frequency matched on age, were children present-
ing with minor trauma and undergoing venous access for clinical pur-
poses. We collected blood samples within 3 weeks of the stroke or at 
the time of enrollment in controls. Approval was obtained from ethics 
review committees at each site.
For this pilot study, we selected plasma samples from the first 161 
cases and 34 trauma controls enrolled into VIPS and used MassTag 
PCR for DNA and RNA to detect 28 common childhood respiratory 
pathogens (Methods in the online-only Data Supplement).4 We con-
firmed infection by performing standard serologies (IgG and IgM) to 
detect an immune response to the pathogen.
Background and Purpose—Case–control studies suggest that acute infection transiently increases the risk of childhood 
arterial ischemic stroke. We hypothesized that an unbiased pathogen discovery approach utilizing MassTag–polymerase 
chain reaction would identify pathogens in the blood of childhood arterial ischemic stroke cases.
Methods—The multicenter international VIPS study (Vascular Effects of Infection in Pediatric Stroke) enrolled arterial 
ischemic stroke cases, and stroke-free controls, aged 29 days through 18 years. Parental interview included questions on 
recent infections. In this pilot study, we used MassTag–polymerase chain reaction to test the plasma of the first 161 cases 
and 34 controls enrolled for a panel of 28 common bacterial and viral pathogens.
Results—Pathogen DNA was detected in no controls and 14 cases (8.7%): parvovirus B19 (n=10), herpesvirus 6 (n=2), 
adenovirus (n=1), and rhinovirus 6C (n=1). Parvovirus B19 infection was confirmed by serologies in all 10; infection 
was subclinical in 8. Four cases with parvovirus B19 had underlying congenital heart disease, whereas another 5 had a 
distinct arteriopathy involving a long-segment stenosis of the distal internal carotid and proximal middle cerebral arteries.
Conclusions—Using MassTag–polymerase chain reaction, we detected parvovirus B19—a virus known to infect erythrocytes 
and endothelial cells—in some cases of childhood arterial ischemic stroke. This approach can generate new, testable hypotheses 
about childhood stroke pathogenesis.   (Stroke. 2017;48:2875-2877. DOI: 10.1161/STROKEAHA.117.018272.)
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We used χ2 tests (or Fisher exact, when appropriate) to compare 
proportions of cases and controls having infection. We combined 
these data with our previously published herpesvirus serological data 
to identify combinations of infections.2
Results
The 161 cases (42% female) had a median age of 7.3 years 
(interquartile range, 1.9–14) and the 34 controls (26% female), 
a median age of 9.1 years (interquartile range, 2.9–14). Per 
parental report, 34% of cases versus 21% of controls reported 
a clinical infection within the prior 4 weeks. Using MassTag 
PCR, we detected microbes in none of the 34 controls and 
14 (8.7%) of 161 cases (P=0.06): parvovirus B19 (n=10), 
human herpesvirus 6 (n=2), adenovirus (n=1), and rhinovirus 
6C (n=1). The copy number of parvovirus B19 in the 10 posi-
tive cases varied from 1.3 to 11×104 per microliter of plasma. 
All 10 had positive (n=9) or equivocal (n=1) parvovirus B19 
IgG serologies confirming infection at some point; 4 had IgM 
antibodies indicating current or recent infection. Based on 
parental interview, only 2 of the 10 parvovirus B19 cases had 
a clinical infection in the prior month; none had slapped check 
syndrome (Table). Four had severe congenital heart disease; 3 
of these had detectable thrombus (intracardiac, n=2; systemic 
venous, n=1). Five parvovirus B19 cases had a distinct arteri-
opathy involving a long segment of the intracranial anterior 
circulation (Figure).
Cases with serological evidence of acute herpesvirus infec-
tions were more likely to be positive for another organism on 
MassTag PCR (Figure I in the online-only Data Supplement): 
9 of 56 (16%) herpes-positive cases versus 5 of 105 (5%) her-
pes-negative cases (P=0.015). Seven of the 9 cases with dual 
infection had parvovirus B19.
Discussion
In this exploratory pilot study, 6% of our cases of childhood 
AIS had parvovirus B19 infections. This common DNA 
virus, transmitted via the upper airway, can cause subclini-
cal infection or flu-like symptoms and, in younger children, 
an exanthema known as slapped cheek syndrome (erythema 
infectiosum). We found no parvovirus B19 DNA in our 
Table. Clinical and Vascular Imaging Characteristics of 14 Cases of Childhood Arterial Ischemic Stroke With a Respiratory 
Pathogen in Serum Detected by MassTag–Polymerase Chain Reaction
Virus Age, y/Sex Race Vascular Imaging Recent Infection*
Acute Herpes 
Infection† Other Clinical History
Parvovirus 15/F Hispanic Long ICA stenosis  HSV History of minor trauma
Parvovirus 7/M White Long ICA stenosis  HSV History of minor trauma
Parvovirus 7/F White Long ICA stenosis  HSV/EBV History of minor trauma
Parvovirus 7/M Black Long ICA stenosis yes HSV Sickle cell, acute chest 
syndrome
Parvovirus 13/F Hispanic Long ICA stenosis yes  Flu-like syndrome
Parvovirus 13/M White M2 occlusion   None
Parvovirus 7/F White M2 occlusion   Severe CHD, intracardiac clot
Parvovirus 1.6/M White Normal yes HSV Severe CHD, intracardiac clot
Parvovirus 4/M Hispanic Normal   Severe CHD, venous clot
Parvovirus 4/M White Normal   Severe CHD
HHV6 16/F White Normal   None
HHV6 0.9/F First nations M1 banding yes HSV Acute febrile illness with 
cough
Adenovirus 2/M Hispanic PICA occlusion yes  Severe CHD, gastroenteritis, 
shock
Rhinovirus 1.9/M White Normal   None
CHD indicates congenital heart disease (defined as severe if required surgical correction); EBV, Epstein-Barr virus; F, female; HHV6, human herpesvirus 6; HSV, herpes 
simplex virus; ICA, internal carotid artery; M, male; M1, proximal segment of middle cerebral artery; and PICA, posterior inferior cerebellar artery.
*Clinical infection in prior 4 weeks, per parental report.
†Serological evidence of acute herpes infection was defined by either positive IgM titers or, when paired samples were available, by rising IgG titers, as detailed in 
reference 2 (Elkind MS et al. Circulation. 2016;133:732-741).
Figure. Brain magnetic resonance angiogram (left) in a case 
with parvovirus B19 and the characteristic long-segment distal 
left internal carotid artery stenosis (arrowheads) and proximal 
left middle cerebral artery irregularity (arrow). Brain diffusion 
weighted imaging (right) in the same case demonstrates a small 
acute left lenticulostriate infarction (asterisk).
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controls; a serum study of 190 healthy individuals similarly 
identified no parvovirus B19 DNA or IgM antibodies.5 Prior 
literature supports the biological plausibility of a link between 
parvovirus, endothelial injury, and AIS: parvovirus B19 infects 
erythrocytes and binds to receptors on endothelial cells and 
has been linked to a wide array of vascular pathologies, includ-
ing post-transplant vasculitis, mononeuritis multiplex, and, in 
case reports, AIS in the young.6–12 In children with sickle cell 
disease, stroke is a described complication of parvovirus B19 
infection.7 Half of our parvovirus cases had complex congeni-
tal heart disease and cardioembolic stroke and half an arteri-
opathy involving a long segment of the distal internal carotid 
artery. We speculate that parvovirus may injure cardiac and 
arterial endothelium, promoting thrombosis or arterial ste-
nosis. A role for parvovirus B19 in childhood stroke patho-
genesis could have treatment implications: complications of 
parvovirus B19 infections, including parvovirus-associated 
vasculitis, have been successfully treated with immunomodu-
latory therapies, including intravenous immune globulin and 
antitumor necrosis factor-α therapy (etanercept).11–14
Combining these pilot data with our previously published her-
pes serology data, we found that, in addition to individual infec-
tions, certain combinations of pathogens—such as a herpesvirus 
and parvovirus B19—may be important in childhood AIS. This 
supports the hypothesis that concurrent infection by multiple 
pathogens explains the paradox of a common exposure (child-
hood infection) associated with a rare outcome (childhood stroke).
Limitations of this pilot study include small sample size, 
potential bias in our control sampling and the inability to test 
for all pathogens, establish the timing of infections, or study 
the host immune response. The viremic phase is short after cer-
tain infections (including herpesviruses), limiting our ability 
to detect such pathogens through PCR of plasma. Respiratory 
samples (not collected in VIPS) may be more sensitive for 
respiratory pathogens. However, this study demonstrates the 
utility of an unbiased approach to pathogen discovery for gen-
erating testable hypotheses about the role for pathogens, and 
combinations of pathogens, in childhood AIS pathogenesis. 
The recently commenced VIPS II study will collect respira-
tory samples, test for a broader array of pathogens, and study 
the host immune response.
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